跳至主要内容
临床试验/NCT01847443
NCT01847443已完成1 期

A Pharmacokinetic Study Comparing Two Nicotine Gum Formulations in a Single Dose Design

GlaxoSmithKline1 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2013年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
84
试验地点
1
主要终点
AUC(0-t) of Nicotine 4 mg Test and Reference Product

研究概览

简要总结

The primary objective of this study is to compare pharmacokinetic (PK) profiles and assess the bioequivalence between the newly developed nicotine gums (2 mg and 4 mg) and the reference nicotine gums (2 mg and 4 mg) in healthy smokers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • BMI within the range of 19 to 30 kilograms/meters^2
  • Current cigarette smokers who have smoked daily for at least a year, and smoke their first cigarette within 30 minutes of waking up

排除标准

  • Participants who have attempted to quit smoking in the last 12 months, are currently attempting to quit smoking or reduce the number of cigarettes they smoke, or are intending to quit smoking in the next 3 months, with or without use of smoking cessation aids
  • Treatment with known hepatic enzyme altering agents

研究组 & 干预措施

Test nicotine gum (2 mg)

Experimental

A single dose of Nicotine Mint Gum (2 mg) to be chewed.

干预措施: Nicotine (2 mg) (Drug)

Test nicotine gum (4 mg)

Experimental

A single dose of Nicotine Mint Gum (4 mg) to be chewed.

干预措施: Nicotine (4 mg) (Drug)

Reference nicotine gum (2 mg)

Active Comparator

A single dose of reference nicotine gum (2 mg) to be chewed.

干预措施: Nicotine (2 mg) (Drug)

Reference nicotine gum (4 mg)

Active Comparator

A single dose of reference nicotine gum (4 mg) to be chewed.

干预措施: Nicotine (4 mg) (Drug)

结局指标

主要结局

AUC(0-t) of Nicotine 4 mg Test and Reference Product

时间窗: Blood samples to be collected from baseline to 12 hours post dose

AUC(0-t) of Nicotine 4 mg test was compared with 4 mg reference gum

Cmax of Nicotine 4 mg Test and Reference Product

时间窗: Blood samples to be collected from baseline to 12 hours post-dose

Cmax for 4 mg test was compared with 4 mg reference gum

Maximum Observed Concentration (Cmax) of Nicotine 2 mg Test and Reference Product

时间窗: Blood samples to be collected from baseline to 12 hours post dose

Cmax for 2 mg test was compared with 2 mg reference gum

Area Under the Curve From Time 0 to Time 't' [AUC(0-t)] of Nicotine 2 mg Test and Reference Product

时间窗: Blood samples to be collected from baseline to 12 hours post dose

AUC(0-t) for 2 mg test was compared with 2 mg reference gum

次要结局

  • Time to Maximum Observed Concentration (Tmax) of Nicotine 2 mg Test and Reference Products, and Nicotine 4 mg Test and Reference Products(Blood samples to be collected from baseline to 12 hours post dose)
  • Apparent Terminal Elimination Half-life (T1/2) of Nicotine 2 mg Test and Reference Products, and Nicotine 4 mg Test and Reference Products(Blood samples to be collected from baseline to 12 hours post dose)
  • Apparent Terminal Elimination Rate Constant (Kel) of Nicotine 2 mg Test and Reference Products, and Nicotine 4 mg Test and Reference Products(Blood samples to be collected from baseline to 12 hours post dose)
  • Area Under Concentration-time Curve From Time 0 Extrapolated to ∞ [AUC(0-∞)] of Nicotine 2 mg Test and Reference Products, and Nicotine 4 mg Test and Reference Products(Blood samples to be collected from baseline to 12 hours post dose)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Comparison of Pharmacokinetic Profiles of Two... | 临床试验